Citigroup’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-37,300
| Closed | -$2.87M | – | 7761 |
|
|
2020
Q4 | $2.87M | Buy |
37,300
+5,700
| +18% | +$427K | ﹤0.01% | 2516 |
|
|
2020
Q3 | $2.36M | Buy |
31,600
+17,200
| +119% | +$1.15M | ﹤0.01% | 2501 |
|
|
2020
Q2 | $906K | Buy |
14,400
+4,000
| +38% | +$220K | ﹤0.01% | 3655 |
|
|
2020
Q1 | $437K | Sell |
10,400
-1,200
| -10% | -$55K | ﹤0.01% | 3993 |
|
|
2019
Q4 | $527K | Buy |
11,600
+300
| +3% | +$14.2K | ﹤0.01% | 4376 |
|
|
2019
Q3 | $517K | Sell |
11,300
-4,100
| -27% | -$230K | ﹤0.01% | 4311 |
|
|
2019
Q2 | $903K | Sell |
15,400
-5,400
| -26% | -$279K | ﹤0.01% | 3752 |
|
|
2019
Q1 | $932K | Sell |
20,800
-100
| -0.5% | -$4.59K | ﹤0.01% | 3488 |
|
|
2018
Q4 | $814K | Buy |
20,900
+2,200
| +12% | +$86.4K | ﹤0.01% | 3610 |
|
|
2018
Q3 | $861K | Buy |
18,700
+6,000
| +47% | +$243K | ﹤0.01% | 3658 |
|
|
2018
Q2 | $554K | Sell |
12,700
-38,100
| -75% | -$1.64M | ﹤0.01% | 3982 |
|
|
2018
Q1 | $2.01M | Buy |
50,800
+18,100
| +55% | +$704K | ﹤0.01% | 2596 |
|
|
2017
Q4 | $1.11M | Buy |
32,700
+4,630
| +16% | +$132K | ﹤0.01% | 3237 |
|
|
2017
Q3 | $716K | Buy |
28,070
+18,770
| +202% | +$431K | ﹤0.01% | 3723 |
|
|
2017
Q2 | $157K | Buy |
9,300
+5,640
| +154% | +$77.3K | ﹤0.01% | 4986 |
|
|
2017
Q1 | $53K | Sell |
3,660
-3,510
| -49% | -$52K | ﹤0.01% | 5657 |
|
|
2016
Q4 | $102K | Buy |
7,170
+2,020
| +39% | +$31.3K | ﹤0.01% | 5763 |
|
|
2016
Q3 | $90K | Sell |
5,150
-1,400
| -21% | -$23.2K | ﹤0.01% | 5279 |
|
|
2016
Q2 | $112K | Buy |
6,550
+2,630
| +67% | +$47K | ﹤0.01% | 4984 |
|
|
2016
Q1 | $77K | Buy |
3,920
+400
| +11% | +$6.41K | ﹤0.01% | 5855 |
|
|
2015
Q4 | $67K | Sell |
3,520
-210
| -6% | -$4.28K | ﹤0.01% | 5704 |
|
|
2015
Q3 | $71K | Buy |
3,730
+730
| +24% | +$24.8K | ﹤0.01% | 5206 |
|
|
2015
Q2 | $139K | Buy |
+3,000
| New | +$130K | ﹤0.01% | 4744 |
|
Citigroup's ARNA Position: Q1 2022 in Review
Citigroup sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 352,641 shares — an estimated $32.8M sold.
Citigroup first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $32.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Citigroup reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Citigroup sold 352,641 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $32.8M.
- Citigroup first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Citigroup's Arena Pharmaceuticals Inc position peaked at $32.8M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.